ABSTRACT
Rationale: Delirium is common in critically ill patients and is associated with deleterious outcomes. Nonpharmacological interventions are recommended in current delirium guidelines, but their effects have not been unequivocally established. Objectives: To determine the effects of a multicomponent nursing intervention program on delirium in the ICU. Methods: A stepped-wedge cluster-randomized controlled trial was conducted in ICUs of 10 centers. Adult critically ill surgical, medical, or trauma patients at high risk of developing delirium were included. A multicomponent nursing intervention program focusing on modifiable risk factors was implemented as standard of care. The primary outcome was the number of delirium-free and coma-free days alive in 28 days after ICU admission. Measurements and Main Results: A total of 1,749 patients were included. Time spent on interventions per 8-hour shift was median (interquartile range) 38 (14-116) minutes in the intervention period and median 32 (13-73) minutes in the control period (P = 0.44). Patients in the intervention period had a median of 23 (4-27) delirium-free and coma-free days alive compared with a median of 23 (5-27) days for patients in the control group (mean difference, -1.21 days; 95% confidence interval, -2.84 to 0.42 d; P = 0.15). In addition, the number of delirium days was similar: median 2 (1-4) days (ratio of medians, 0.90; 95% confidence interval, 0.75 to 1.09; P = 0.27). Conclusions: In this large randomized controlled trial in adult ICU patients, a limited increase in the use of nursing interventions was achieved, and no change in the number of delirium-free and coma-free days alive in 28 days could be determined. Clinical trial registered with www.clinicaltrials.gov (NCT03002701).
Subject(s)
Critical Care Nursing/methods , Critical Care/methods , Delirium/nursing , Delirium/prevention & control , Adolescent , Adult , Aged , Aged, 80 and over , Coma/etiology , Coma/nursing , Coma/prevention & control , Combined Modality Therapy , Delirium/etiology , Female , Follow-Up Studies , Humans , Intensive Care Units , Male , Middle Aged , Risk Factors , Treatment Outcome , Young AdultABSTRACT
AIM: To identify the effects of each domain of the early and modified ABCDE bundle on post-intensive care syndrome (PICS). DESIGN: This is a retrospective study. METHODS: We analysed the data from electronic medical records of 91 intensive care patients who received therapeutic interventions in stages, based on the early ABCDE bundle (admitted to the intensive care unit [ICU] from June - August 2013) and 94 patients who received interventions using a modified ABCDE bundle developed through continuous quality improvement activities (admitted to the ICU from June to August 2014). RESULTS: In the ABC domain, the percentage of patients showing sedation levels of alertness and calmness increased significantly from 58.2% using the early ABCDE bundle to 72.4% using the modified ABCDE bundle. Coma prevalence decreased significantly from 45.1% using the early ABCDE bundle to 28.7% using the modified ABCDE bundle. In the E domain, the percentage of patients receiving early mobility interventions increased significantly from 11% using the early ABCDE bundle to 54.3% using the modified ABCDE bundle. CONCLUSION: The ABCDE bundle in the ICU helped prevent PICS by reducing deep sedation and immobilization among intensive care patients. To effectively use the ABCDE bundle, it is necessary for institutions to develop suitable protocols for each constituent element and to test their effectiveness. IMPACT: The ABCDE bundle was a suitable tool to support evidence-based practice in intensive care patients, including oversedation and immobilization, which is related to the prevention of PICS. Individual institutions will need to actively use the ABCDE bundle in the ICU, by developing protocols and testing their effectiveness.
Subject(s)
Chronic Disease/nursing , Coma/prevention & control , Critical Care/methods , Critical Illness/nursing , Delirium/prevention & control , Length of Stay/statistics & numerical data , Walking/physiology , Adult , Aged , Aged, 80 and over , Critical Care/statistics & numerical data , Female , Humans , Male , Middle Aged , Retrospective Studies , Survivors/statistics & numerical dataABSTRACT
Objective Patients on outpatient insulin therapy are at a high risk of severe hypoglycemia and a high incidence of hypoglycemic coma. However, only a few studies have explored the risk factors for hypoglycemic coma in such patients. We retrospectively analyzed the clinical characteristics of diabetic patients who had developed hypoglycemic coma during outpatient insulin therapy. Methods This study included 33 diabetic patients on insulin therapy who were transported to the hospital by ambulance for severe hypoglycemia. Patients with a Japan Coma Scale score <100 were classified as the non-coma group (n=18), while those with a score ≥100 (n=15) were classified into the coma group. Results Patients in the coma group were significantly older, with a higher proportion of elderly patients ( ≥65 years of age), than those in the non-coma group. Although no marked difference in the basal insulin dose was observed between the two groups, the bolus insulin dose was significantly higher in the coma group. However, no marked differences in the disease type or renal function were noted between the two groups. Conclusion An advanced age and bolus insulin dose are risk factors for hypoglycemic coma in diabetic patients on insulin therapy. Bolus insulin dose minimization should be performed in order to prevent hypoglycemic coma, especially in elderly diabetic patients.
Subject(s)
Coma/drug therapy , Coma/prevention & control , Diabetes Mellitus, Type 1/drug therapy , Hypoglycemia/drug therapy , Hypoglycemic Agents/therapeutic use , Insulin/therapeutic use , Outpatients/statistics & numerical data , Aged , Aged, 80 and over , Ambulances/statistics & numerical data , Female , Hospitalization/statistics & numerical data , Humans , Japan , Male , Middle Aged , Retrospective Studies , Risk FactorsABSTRACT
BACKGROUND: Delirium in critically ill patients is associated with poor clinical outcomes. Neuroinflammation might be an important mechanism in the pathogenesis of delirium, and since simvastatin has anti-inflammatory properties it might reduce delirium. We aimed to establish whether early treatment with simvastatin would decrease the time that survivors of critical illness spent in delirium or coma. METHODS: We undertook this randomised, double-blind, placebo-controlled trial in a general adult intensive care unit (ICU) in Watford General Hospital (Watford, UK). We enrolled critically ill patients (≥18 years) needing mechanical ventilation within 72 h of admission. We randomly assigned patients (1:1 ratio) to receive either simvastatin 80 mg or placebo daily for up to a maximum of 28 days, irrespective of coma or delirium status. We assessed delirium using the Confusion Assessment Method for the ICU (CAM-ICU). The primary outcome was number of days alive and was assessed as delirium-free and coma-free in the first 14 days after being randomly allocated to receive treatment or placebo. ICU clinical and research staff and patients were masked to treatment. We did intention-to-treat analyses with no extrapolation. This trial is registered with the International Standard Randomised Controlled Trial Registry, number ISRCTN89079989. FINDINGS: Between Feb 1, 2013, and July 29, 2016, 142 patients were randomly assigned to receive simvastatin (n=71) or placebo (n=71), and were included in the final analysis. The mean number of days alive without delirium and without coma at day 14 did not differ significantly between the two groups (5·7 days [SD 5·1] with simvastatin and 6·1 days [5·2] with placebo; mean difference 0·4 days, 95% CI -1·3 to 2·1; p=0·66). The most common adverse event was an elevated creatine kinase concentration to more than ten times the upper limit of normal (eight [11%] in the simvastatin group vs three [4%] in the placebo group p=0·208). No patient had a serious adverse event related to the study drug. INTERPRETATION: These results do not support the hypothesis that simvastatin modifies duration of delirium and coma in critically ill patients. FUNDING: National Institute for Health Research.
Subject(s)
Anti-Inflammatory Agents/administration & dosage , Critical Care/methods , Delirium/drug therapy , Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage , Respiration, Artificial , Simvastatin/administration & dosage , Aged , Coma/drug therapy , Coma/prevention & control , Critical Illness/therapy , Delirium/prevention & control , Double-Blind Method , Drug Administration Schedule , Female , Humans , Intensive Care Units , Male , Middle Aged , Time Factors , Treatment OutcomeABSTRACT
BACKGROUND: The occurrence of meningitis in children >5 years old may be associated with specific predisposing factors that can be anatomic, such as cerebrospinal fluid fistula or breach, or related to genetic susceptibility or N inborn or acquired immunologic defect. This study aimed to assess the anatomical and immunologic risk factors in children >5 years old with pneumococcal meningitis and prospectively enrolled in the French national meningitis network. METHODS: We analyzed all data for children who were 5-15 years old with a diagnosis of pneumococcal meningitis between 2001 and 2013. We describe the frequency and typology of the anatomic or immunologic risk factors, the clinical features and the pneumococcal serotypes. RESULTS: Among the 316 patients with pneumococcal meningitis, the mortality rate was 9.5% and 23.1% of cases presented complications (abscess, coma, hemodynamic failure, thrombophlebitis cerebral or deafness). In total, 108 children (34%) showed risk factors, the most frequent being anatomic: 70 cases (22.8%) were related to a cerebrospinal fluid breach or fistula and 55 (17.9%) to immunodeficiency, primary or acquired. Serotype data were available for 207 pneumococcal isolates (65.5%). The most frequent serotypes were as follows: 3, 18C, 19A and 19F between 2001 and 2009 and 19F, 3, 19A, 12F, 22F, 17F and 24F after 2009. CONCLUSIONS: We describe the largest cohort of children >5 years old with pneumococcal meningitis. One third of the children had risk factors justifying a complete immunologic and radiologic work-up.
Subject(s)
Immunologic Deficiency Syndromes/diagnosis , Immunologic Deficiency Syndromes/prevention & control , Meningitis, Pneumococcal/diagnosis , Pneumococcal Vaccines/administration & dosage , Streptococcus pneumoniae/pathogenicity , Vaccination , Abscess/diagnosis , Abscess/etiology , Abscess/mortality , Abscess/prevention & control , Adolescent , Child , Child, Preschool , Coma/diagnosis , Coma/etiology , Coma/mortality , Coma/prevention & control , Deafness/diagnosis , Deafness/etiology , Deafness/mortality , Deafness/prevention & control , Female , France , Humans , Immunologic Deficiency Syndromes/complications , Immunologic Deficiency Syndromes/mortality , Male , Meningitis, Pneumococcal/complications , Meningitis, Pneumococcal/mortality , Meningitis, Pneumococcal/prevention & control , Prospective Studies , Risk Factors , Serogroup , Streptococcus pneumoniae/classification , Streptococcus pneumoniae/isolation & purification , Survival Analysis , Thrombophlebitis/diagnosis , Thrombophlebitis/etiology , Thrombophlebitis/mortality , Thrombophlebitis/prevention & controlABSTRACT
OBJECTIVE: In the present study, we aimed to determine the effects of a system-wide approach from the community to the hospital in improving the neurologic outcomes in out-of-hospital cardiac arrest (OHCA) patients within Sungbuk in Korea. METHODS: This study used a before-after design. In 2011, compression-only cardiopulmonary resuscitation (CPR) for citizens, a state-wide standard dispatcher assisted-CPR protocol, medical control for regional emergency medical service (EMS), provision of high-quality advanced cardiac life support (ACLS) with capnography and extracorporeal CPR, and the standard postcardiac arrest care protocol were implemented in the system-wide CPR program. CPR provision and outcomes were compared between the 2009-2010 and the 2012-2013 periods. A multivariate logistic regression model for good outcome of OHCA was used to identify interventions with a significant impact. RESULTS: In total, 581 adult nontraumatic OHCA patients who received resuscitation attempts from 2009 to 2013 were selected for the analysis of CPR provision and outcomes. CPR provision improved significantly, as indicated by the following results from 2009-2010 to 2012-2013: from 15.9 to 50.4% for bystander CPR (P<0.001), 6.0 to 0% for the proportion of no documented arrest rhythm by EMS (P=0.004), 41.4 to 62.2% for ACLS with capnography (P=0.008), 1.4 to 10.5% for extracorporeal CPR (P=0.052), 3.7 to 34.4% for successful therapeutic hypothermia in coma patients (P<0.001), and 61.5 to 87.1% for immediate coronary angiography for presumed cardiac etiology (P=0.005). Moreover, the proportion of OHCA patients who received early EMS activation, bystander CPR, appropriate attempt of defibrillation at the prehospital level, high-quality ACLS, and standard postcardiac arrest care increased from 0.5% in 2009-2010 to 8.5% in 2012-2013 (P<0.001). The rates of discharge with a good neurologic outcome improved from 3.3% in 2009-2010 to 8.5% in 2012-2013 (P<0.001). CONCLUSION: The system-wide CPR program was associated with enhancements in CPR performance at both the prehospital and the hospital level, and yielded improved neurologic outcomes in OHCA patients in a small region.
Subject(s)
Coma/prevention & control , Emergency Medical Services , Out-of-Hospital Cardiac Arrest/therapy , Quality Improvement , Aged , Cardiopulmonary Resuscitation/methods , Controlled Before-After Studies , Emergency Medical Services/methods , Emergency Medical Services/organization & administration , Female , Humans , Hypothermia, Induced/methods , Male , Out-of-Hospital Cardiac Arrest/complications , Treatment OutcomeABSTRACT
OBJECTIVES: To track compliance by an interprofessional team with the Awakening and Breathing Coordination, Choice of drugs, Delirium monitoring and management, Early mobility, and Family engagement (ABCDEF) bundle in implementing the Pain, Agitation, and Delirium guidelines. The aim was to study the association between ABCDEF bundle compliance and outcomes including hospital survival and delirium-free and coma-free days in community hospitals. DESIGN: A prospective cohort quality improvement initiative involving ICU patients. SETTING: Seven community hospitals within California's Sutter Health System. PATIENTS: Ventilated and nonventilated general medical and surgical ICU patients enrolled between January 1, 2014, and December 31, 2014. MEASUREMENTS AND MAIN RESULTS: Total and partial bundle compliance were measured daily. Random effects regression was used to determine the association between ABCDEF bundle compliance accounting for total compliance (all or none) or for partial compliance ("dose" or number of bundle elements used) and outcomes of hospital survival and delirium-free and coma-free days, after adjusting for age, severity of illness, and presence of mechanical ventilation. Of 6,064 patients, a total of 586 (9.7%) died before hospital discharge. For every 10% increase in total bundle compliance, patients had a 7% higher odds of hospital survival (odds ratio, 1.07; 95% CI, 1.04-1.11; p < 0.001). Likewise, for every 10% increase in partial bundle compliance, patients had a 15% higher hospital survival (odds ratio, 1.15; 95% CI, 1.09-1.22; p < 0.001). These results were even more striking (12% and 23% higher odds of survival per 10% increase in bundle compliance, respectively, p < 0.001) in a sensitivity analysis removing ICU patients identified as receiving palliative care. Patients experienced more days alive and free of delirium and coma with both total bundle compliance (incident rate ratio, 1.02; 95% CI, 1.01-1.04; p = 0.004) and partial bundle compliance (incident rate ratio, 1.15; 95% CI, 1.09-1.22; p < 0.001). CONCLUSIONS: The evidence-based ABCDEF bundle was successfully implemented in seven community hospital ICUs using an interprofessional team model to operationalize the Pain, Agitation, and Delirium guidelines. Higher bundle compliance was independently associated with improved survival and more days free of delirium and coma after adjusting for age, severity of illness, and presence of mechanical ventilation.
Subject(s)
Delirium/prevention & control , Guideline Adherence/statistics & numerical data , Hospitals, Community/statistics & numerical data , Intensive Care Units/statistics & numerical data , Patient Care Bundles/methods , California , Coma/prevention & control , Critical Care/methods , Critical Care/standards , Female , Hospital Mortality , Hospitals, Community/methods , Humans , Male , Middle Aged , Patient Care Bundles/mortality , Prospective Studies , Quality Improvement , Treatment OutcomeABSTRACT
Flumazenil and naloxone are considered to be pharmacologically ideal antidotes. By competitive binding at the molecular target receptors, they are highly specific antagonists of two important drug classes, the benzodiazepines and opioids, respectively. Both antidotes enjoy rapid onset and short duration after parenteral administration, are easily titrated and are essentially devoid of agonist effects. Yet only naloxone is widely used as a component of the 'coma cocktail', a sequence of empirical treatments to correct altered mental status, while experts discourage the use of flumazenil for such patients. This review contrasts the history, indications, published evidence and novel applications for each antidote in order to explain this disparity in the clinical use of these 'ideal' antidotes.
Subject(s)
Analgesics, Opioid/antagonists & inhibitors , Benzodiazepines/antagonists & inhibitors , Coma/chemically induced , Coma/drug therapy , Drug Overdose/drug therapy , Flumazenil/therapeutic use , Naloxone/therapeutic use , Analgesics, Opioid/poisoning , Antidotes/therapeutic use , Benzodiazepines/poisoning , Coma/prevention & control , HumansABSTRACT
Anaortic coronary artery bypass proved to prevent early neurologic injury compared to on-pump CABG. The Cardica PAS-Port(®) is a fully automated device that might be able to perform proximal aorto-venous anastomoses without an increased embolic risk. We evaluated early post-operative neurologic outcome in a matched population following clampless OPCAB (CCAB: either "all-arterial" or with automatically anastomosed venous grafts) or on-pump CABG. 366 consecutive patients were submitted to isolated coronary bypass by a single surgeon experienced in both off and on-pump procedures between January 2009 and December 2013. Of these patients, 223 underwent a clampless off-pump revascularization. After propensity score matching, 143 pairs were selected, who received either off-pump or on-pump surgery. In the off-pump group, CCAB was performed with an all-arterial approach (n = 33) or with automated proximal anastomosis of the venous graft(s) by means of the Cardica PAS-Port(®) connector (n = 110). Neurologic injury was defined as non-reversible (NRNI: lethal coma or stroke) or reversible (RNI: TIA or delirium). Operative mortality was 2.4 % (CCAB 1.4 %; CABG 3.5 %; p = 0.14). The global rate of early neurologic injury was 5.6 % (CCAB 2.1 vs. CABG 9.1 %; p = 0.006). Incidence was 1.4 % for NRNI (CCAB 0 vs. CABG 2.8 %; p = 0.04) and 4.2 % for RNI (CCAB 2.1 vs. CABG 6.3 %; p = 0.06). No differences were found among other major perioperative outcomes. CCAB prevents both early post-operative RNI and NRNI. This result can be achieved with a totally anaortic strategy and also with the aid of a fully automated device for proximal aorto-venous anastomoses.
Subject(s)
Cardiopulmonary Bypass , Cerebrovascular Disorders/prevention & control , Coronary Artery Bypass, Off-Pump , Coronary Artery Bypass/methods , Aged , Cardiopulmonary Bypass/adverse effects , Cardiopulmonary Bypass/mortality , Cerebrovascular Disorders/diagnosis , Cerebrovascular Disorders/etiology , Cerebrovascular Disorders/mortality , Chi-Square Distribution , Coma/etiology , Coma/prevention & control , Coronary Artery Bypass/adverse effects , Coronary Artery Bypass/mortality , Coronary Artery Bypass, Off-Pump/adverse effects , Coronary Artery Bypass, Off-Pump/instrumentation , Coronary Artery Bypass, Off-Pump/mortality , Delirium/etiology , Delirium/prevention & control , Equipment Design , Female , Hospital Mortality , Humans , Ischemic Attack, Transient/etiology , Ischemic Attack, Transient/prevention & control , Logistic Models , Male , Middle Aged , Odds Ratio , Propensity Score , Risk Factors , Stroke/etiology , Stroke/prevention & control , Time Factors , Treatment OutcomeABSTRACT
BACKGROUND: Acute hydrogen sulfide (H2S) poisoning produces a coma, the outcome of which ranges from full recovery to severe neurological deficits. The aim of our study was to 1--describe the immediate and long-term neurological effects following H2S-induced coma in un-anesthetized rats, and 2--determine the potential benefit of methylene blue (MB), a compound we previously found to counteract acute sulfide cardiac toxicity. METHODS: NaHS was administered IP in un-sedated rats to produce a coma (n = 34). One minute into coma, the rats received MB (4 mg/kg i.v.) or saline. The surviving rats were followed clinically and assigned to Morris water maze (MWM) and open field testing then sacrificed at day 7. RESULTS: Sixty percent of the non-treated comatose rats died by pulseless electrical activity. Nine percent recovered with neurological deficits requiring euthanasia, their brain examination revealed major neuronal necrosis of the superficial and middle layers of the cerebral cortex and the posterior thalamus, with variable necrosis of the caudate putamen, but no lesions of the hippocampus or the cerebellum, in contrast to the typical distribution of post-ischemic lesions. The remaining animals displayed, on average, a significantly less effective search strategy than the control rats (n = 21) during MWM testing. Meanwhile, 75% of rats that received MB survived and could perform the MWM test (P<0.05 vs non-treated animals). The treated animals displayed a significantly higher occurrence of spatial search than the non-treated animals. However, a similar proportion of cortical necrosis was observed in both groups, with a milder clinical presentation following MB. CONCLUSION: In conclusion, in rats surviving H2S induced coma, spatial search patterns were used less frequently than in control animals. A small percentage of rats presented necrotic neuronal lesions, which distribution differed from post-ischemic lesions. MB dramatically improved the immediate survival and spatial search strategy in the surviving rats.
Subject(s)
Brain/metabolism , Coma/chemically induced , Coma/prevention & control , Hydrogen Sulfide/poisoning , Methylene Blue/pharmacology , Neurons/metabolism , Animals , Brain/pathology , Coma/metabolism , Coma/pathology , Male , Necrosis , Neurons/pathology , Rats , Rats, Sprague-DawleyABSTRACT
OBJECTIVES: Mechanically ventilated critically ill patients receive significant amounts of sedatives and analgesics that increase their risk of developing coma and delirium. We evaluated the impact of a "Wake-up and Breathe Protocol" at our local ICU on sedation and delirium. DESIGN: A pre/post implementation study design. SETTING: A 22-bed mixed surgical and medical ICU. PATIENTS: Seven hundred two consecutive mechanically ventilated ICU patients from June 2010 to January 2013. INTERVENTIONS: Implementation of daily paired spontaneous awakening trials (daily sedation vacation plus spontaneous breathing trials) as a quality improvement project. MEASUREMENTS AND MAIN RESULTS: After implementation of our program, there was an increase in the mean Richmond Agitation Sedation Scale scores on weekdays of 0.88 (p < 0.0001) and an increase in the mean Richmond Agitation Sedation Scale scores on weekends of 1.21 (p < 0.0001). After adjusting for age, race, gender, severity of illness, primary diagnosis, and ICU, the incidence and prevalence of delirium did not change post implementation of the protocol (incidence: 23% pre vs 19.6% post; p = 0.40; prevalence: 66.7% pre vs 55.3% post; p = 0.06). The combined prevalence of delirium/coma decreased from 90.8% pre protocol implementation to 85% postimplementation (odds ratio, 0.505; 95% CI, 0.299-0.853; p = 0.01). CONCLUSIONS: Implementing a "Wake Up and Breathe Program" resulted in reduced sedation among critically ill mechanically ventilated patients but did not change the incidence or prevalence of delirium.
Subject(s)
Critical Illness , Deep Sedation/methods , Delirium/prevention & control , Respiration, Artificial/methods , Respiration , Adult , Aged , Clinical Protocols , Coma/prevention & control , Female , Humans , Incidence , Intensive Care Units , Length of Stay , Male , Middle AgedABSTRACT
The Z-drugs zolpidem, zopiclone, and zaleplon were hailed as the innovative hypnotics of the new millennium, an improvement to traditional benzodiazepines in the management of insomnia. Increasing reports of adverse events including bizarre behavior and falls in the elderly have prompted calls for caution and regulation. Z-drugs have significant hypnotic effects by reducing sleep latency and improving sleep quality, though duration of sleep may not be significantly increased. Z-drugs exert their effects through increased γ-aminobutyric acid (GABA) transmission at the same GABA-type A receptor as benzodiazepines. Their pharmacokinetics approach those of the ideal hypnotic with rapid onset within 30 min and short half-life (1-7 h). Zopiclone with the longest duration of action has the greatest residual effect, similar to short-acting benzodiazepines. Neuropsychiatric adverse events have been reported with zolpidem including hallucinations, amnesia, and parasomnia. Poisoning with Z-drugs involves predominantly sedation and coma with supportive management being adequate in the majority. Flumazenil has been reported to reverse sedation from all three Z-drugs. Deaths from Z-drugs are rare and more likely to occur with polydrug overdose. Z-drugs can be detected in blood, urine, oral fluid, and postmortem specimens, predominantly with liquid chromatography-mass spectrometry techniques. Zolpidem and zaleplon exhibit significant postmortem redistribution. Zaleplon with its ultra-short half-life has been detected in few clinical or forensic cases possibly due to assay unavailability, low frequency of use, and short window of detection. Though Z-drugs have improved pharmacokinetic profiles, their adverse effects, neuropsychiatric sequelae, and incidence of poisoning and death may prove to be similar to older hypnotics.
Subject(s)
Acetamides/adverse effects , Azabicyclo Compounds/adverse effects , GABA-A Receptor Agonists/adverse effects , Hypnotics and Sedatives/adverse effects , Piperazines/adverse effects , Pyridines/adverse effects , Pyrimidines/adverse effects , Acetamides/pharmacokinetics , Acetamides/poisoning , Azabicyclo Compounds/pharmacokinetics , Azabicyclo Compounds/poisoning , Coma/etiology , Coma/prevention & control , Drug Overdose/drug therapy , Drug Overdose/mortality , Drug Overdose/physiopathology , Flumazenil/therapeutic use , GABA Modulators/therapeutic use , GABA-A Receptor Agonists/pharmacokinetics , GABA-A Receptor Agonists/poisoning , Humans , Hypnotics and Sedatives/pharmacokinetics , Hypnotics and Sedatives/poisoning , Piperazines/pharmacokinetics , Piperazines/poisoning , Pyridines/pharmacokinetics , Pyridines/poisoning , Pyrimidines/pharmacokinetics , Pyrimidines/poisoning , ZolpidemSubject(s)
Anticonvulsants/poisoning , Drug Overdose/therapy , Medication Errors/adverse effects , Neurotoxicity Syndromes/therapy , Valproic Acid/poisoning , Anticonvulsants/blood , Anticonvulsants/pharmacokinetics , Child, Preschool , Coma/etiology , Coma/prevention & control , Drug Overdose/blood , Drug Overdose/physiopathology , Female , Half-Life , Hemofiltration , Humans , Neurotoxicity Syndromes/blood , Neurotoxicity Syndromes/physiopathology , Treatment Outcome , Valproic Acid/blood , Valproic Acid/pharmacokineticsABSTRACT
BACKGROUND: Lithium is widely used to treat bipolar disorders. Lithium toxicity is generally caused by inappropriately high doses of lithium or impaired lithium excretion. Most lithium is eliminated via the kidneys and, since thyroid hormone increases tubular reabsorption of lithium, thyrotoxicosis could contribute to the development of lithium toxicity. We report a case of severe lithium toxicity that was apparently precipitated by the onset of thyrotoxicosis resulting from silent thyroiditis and dehydration. PATIENT FINDINGS: The patient was a 64-year-old woman who was admitted for muscle weakness in the lower extremities, diarrhea, and palpitations. She had bipolar disorder and was being treated with lithium carbonate, which she discontinued one week before admission. Her circulating lithium levels had been monitored yearly. Early in her admission she was dehydrated and had febrile episodes, paroxysmal atrial fibrillation, and muscle weakness. Initially, fluid therapy was started, but she lost consciousness and had a cardiac arrest for 2 minutes due to prolonged sinus arrest. Chest compression and manual artificial ventilation were performed, and body surface pacing was started. Serum lithium was markedly elevated to 3.81 mEq/L (therapeutic range, 0.4-1.0 mEq/L), and thyroid hormone levels were increased (free triiodothyronine, 8.12 pg/mL; free thyroxine, 4.45 ng/dL), while thyrotropin (TSH) was suppressed (<0.01 µIU/mL). Hemodialysis was performed, and a temporary pacemaker was inserted for severe sinus bradycardia. The serum thyroglobulin was 4680 ng/mL (reference range, <32.7 ng/mL). A TSH receptor antibody test was negative. Glucocorticoid therapy and inorganic iodine (100 mg) were administered and continued until day 11. However, her neurological symptoms deteriorated with floppy quadriplegia and deep coma. She gradually recovered. On day 36, she was discharged without any neurological symptoms or thyrotoxicosis. SUMMARY: A 64-year-old woman taking lithium for bipolar disorder developed lithium toxicity in the setting of what seemed likely to be a recent onset of thyrotoxicosis due to silent thyroiditis. CONCLUSIONS: Thyrotoxicosis may be a contributing cause of lithium toxicity, particularly if it is abrupt in onset and even with cessation of lithium therapy if renal function is compromised. Thyroid function should be assessed immediately in patients with suspected lithium toxicity.
Subject(s)
Coma/etiology , Dehydration/physiopathology , Heart Arrest/etiology , Lithium Carbonate/adverse effects , Quadriplegia/etiology , Thyroiditis/physiopathology , Thyrotoxicosis/etiology , Antimanic Agents/adverse effects , Antimanic Agents/therapeutic use , Bipolar Disorder/complications , Bipolar Disorder/drug therapy , Coma/prevention & control , Dehydration/complications , Dehydration/therapy , Drug Monitoring , Female , Heart Arrest/physiopathology , Heart Arrest/therapy , Humans , Lithium/blood , Lithium Carbonate/therapeutic use , Middle Aged , Quadriplegia/prevention & control , Severity of Illness Index , Sinus Arrest, Cardiac/chemically induced , Sinus Arrest, Cardiac/etiology , Thyroid Gland/physiopathology , Thyroiditis/complications , Thyroiditis/drug therapy , Thyrotoxicosis/blood , Thyrotoxicosis/chemically induced , Thyrotoxicosis/physiopathology , Treatment OutcomeABSTRACT
OBJECTIVE: To report a case of reversible chorea in a woman with myxedema coma. METHODS: We describe the clinical course, imaging findings, and laboratory test results of a patient who initially presented with myxedema coma and then developed reversible chorea upon treatment. RESULTS: A 33-year-old woman with a known history of primary hypothyroidism presented with a 3-week history of lethargy, progressing to a precipitous decline in consciousness that required intubation. Physical examination revealed concurrent hypothermia and bradycardia. Laboratory investigations demonstrated a thyrotropin concentration greater than 100 mIU/L, a free triiodothyronine concentration of 1.9 pg/mL, and a free thyroxine concentration of 0.24 ng/dL, but no other metabolic abnormalities. She was treated with intravenous levothyroxine therapy on the first 2 days of hospital admission (200 mcg and 250 mcg, respectively). On day 2, she was obeying commands and she was extubated. She began exhibiting choreiform movements. Thyroid function test results revealed a normal free thyroxine concentration (1.10 ng/dL), but an elevated thyrotropin concentration (40.98 mIU/L) and a low free triiodothyronine concentration (1.9 pg/mL). Findings from computed tomography and magnetic resonance imaging of her brain and analysis of cerebrospinal fluid were normal. Her regimen was transitioned to oral levothyroxine, 88 mcg daily, and by day 4, her choreiform movements ceased. CONCLUSIONS: Neurologic manifestations of hypothyroidism include psychomotor slowing, memory deficits, and dementia, with myxedema coma at the extreme of this spectrum. Although chorea is a rare manifestation of hyperthyroidism, this is the first report of a patient with acquired, reversible choreiform movement disorder while still being severely hypothyroid and treated with levothyroxine.
Subject(s)
Chorea/prevention & control , Coma/prevention & control , Hormone Replacement Therapy , Hypothyroidism/diagnosis , Hypothyroidism/drug therapy , Myxedema/prevention & control , Thyroxine/therapeutic use , Adult , Bradycardia/etiology , Bradycardia/prevention & control , Chorea/etiology , Coma/etiology , Diagnosis, Differential , Female , Humans , Hypothermia/etiology , Hypothermia/prevention & control , Hypothyroidism/blood , Hypothyroidism/physiopathology , Myxedema/etiology , Severity of Illness Index , Thyroxine/blood , Treatment Outcome , Triiodothyronine/bloodSubject(s)
Analgesia/methods , Analgesics/therapeutic use , Clinical Protocols , Coma/prevention & control , Critical Care/methods , Dementia/prevention & control , Hypnotics and Sedatives/therapeutic use , Analgesia/adverse effects , Analgesics/adverse effects , Antipsychotic Agents/therapeutic use , Checklist , Coma/chemically induced , Coma/mortality , Critical Illness , Dementia/chemically induced , Dementia/mortality , Humans , Hypnotics and Sedatives/adverse effects , Iatrogenic Disease , Intensive Care Units , Length of Stay , Pain Measurement , Respiration, Artificial , Risk Assessment , Risk Factors , Time FactorsABSTRACT
An autoimmune thyroiditis represents the main reason of hypothyroidism, defined as a lack of thyroid hormone. This autoimmune process results in destruction of functioning thyroid follicles. While subclinical or latent hypothyroidism is defined on the basis of laboratory values (an elevation of TSH with normal peripheral hormone levels), the typical signs and symptoms are associated with hypothyroidism. In about 80% of cases antibodies against thyroid peroxidase can be measured, but only in about 40-50% of cases antibodies against thyroglobulin are detectable. If hypothyrodism has been diagnosed, substitution with levothyroxine should be initiated, with the therapeutic goal to decrease TSH level to the lower normal range. In cases of subclinical hypothyroidism, levothyroxine medication should be started in patients with a high TSH value, positive antibodies and/or the typical ultrasound of autoimmune thyroiditis. However, substitution with levothyroxine in any case of elevated TSH values should be avoided.
Subject(s)
Coma/prevention & control , Hypothyroidism/diagnosis , Hypothyroidism/therapy , Thyroiditis, Autoimmune/diagnosis , Thyroiditis, Autoimmune/therapy , Thyrotropin/blood , Thyroxine/therapeutic use , Coma/diagnosis , Coma/etiology , Humans , Hypothyroidism/etiology , Thyroiditis, Autoimmune/complicationsABSTRACT
BACKGROUND: Sedatives and analgesics, in doses that alter consciousness in the intensive care unit (ICU), contribute to delirium and mortality. Pain, agitation, and delirium can be monitored in ICU patients. These symptoms were noted before (PRE) and after (POST) a protocol to alleviate undesirable symptoms. Analgesia and sedation levels, the incidence of coma, delirium, length of stay (LOS), discharge location, and mortality were then compared. We hypothesized that the likely reduction in iatrogenic coma would result in less delirium, because these 2 morbid conditions seem to be linked. METHODS: All patients were consecutively admitted to an ICU PRE-protocol (August 2003 to February 2004, 610 patients) and POST-protocol (April 2005 to November 2005, 604 patients). Between February 2004 and April 2005, we piloted and taught individualized nonpharmacologic strategies and titration of analgesics, sedatives, and antipsychotics based on sedation, analgesia, and delirium scores. We measured the following outcomes: coma, delirium, LOS, mortality, and discharge location. RESULTS: The POST group benefited from better analgesia, received less opiates (90.72 + or - 207.45 vs 22.93 + or - 40.36 morphine equivalents/d, P = <0.0001), and, despite comparable sedation, had shorter duration of mechanical ventilation. Medication-induced coma rates (18.1%vs 7.2%, P < 0.0001), ICU and hospital LOS, and dependency at discharge were lower in the POST-protocol group. Subsyndromal delirium was significantly reduced; delirium was similar. The 30-day mortality risk in the PRE cohort was 29.4% vs 22.9% in the POST cohort (log-rank test, P = 0.009). CONCLUSION: Educational initiatives incorporating systematic management protocols with nonpharmacologic measures and individualized titration of sedation, analgesia, and delirium therapies are associated with better outcomes.
Subject(s)
Analgesia/methods , Analgesics/therapeutic use , Clinical Protocols , Coma/prevention & control , Critical Care/methods , Delirium/prevention & control , Hypnotics and Sedatives/therapeutic use , APACHE , Aged , Analgesia/adverse effects , Analgesics/adverse effects , Antipsychotic Agents/therapeutic use , Checklist , Coma/chemically induced , Coma/mortality , Critical Illness , Delirium/chemically induced , Delirium/mortality , Female , Humans , Hypnotics and Sedatives/adverse effects , Iatrogenic Disease , Incidence , Intensive Care Units , Length of Stay , Male , Middle Aged , Ontario , Pain Measurement , Patient Discharge , Prospective Studies , Respiration, Artificial , Risk Assessment , Risk Factors , Time FactorsSubject(s)
Anticonvulsants/poisoning , Coma/chemically induced , Coma/prevention & control , Drug Overdose , Humans , Time FactorsABSTRACT
AIM: The purpose of this study was to determine the effect of a regular family visiting program, as an auditory, affective, and tactile stimulation, on the consciousness level of comatose head injury patients. METHOD: A randomized controlled trial design was used. Fifty comatose head injury patients were randomly allocated into a control group or an intervention group. The consciousness level of the patients in both groups was evaluated and recorded by the Glasgow Coma Scale, before and 30 min after the visiting program. RESULTS: The independent t-test results demonstrated that the means of the consciousness level at the first day before intervention had no significant difference in both groups. The repeated measured ANOVA results demonstrated that the consciousness level alterations were significant between the two groups over the 6 days of intervention. CONCLUSION: The results of the present study provided evidence to support that a regular family visiting program could induce the stimulation of comatose patients. Therefore, it can be considered as a potential nursing intervention.